Congratulations on starting your weight loss journey

Thank you for completing your assessment. Your eligibility results will be emailed to you shortly (double check your junk inbox)

We are excited that you have chosen to start your weight loss journey with us. If you have any questions about the medication or the next few steps, please get in touch.

The next Steps

Setting Up Your Account

The next step is to set up a GoCardless account for your future monthly direct debit. No payments will be setup or taken until you have been approved by our consultants, but this will move you onto the verification stage. Click on the link below to get started. Once setup, one of our patient care coordinators will process* your account & request your ID & weight verifications. 

*Manual processing takes place during office hours on weekdays from 9am-5pm. 

Medical Review

Once your account has been set up & verified, your assessment will be reviewed by one of our specialist consultants – if anything needs clarification we will contact you for more information. Once approved, the team will then setup your payments & authorise delivery for the earliest date available. * If you have a preferred time of the month you would like payments to be taken, let the team know/this can be arranged

Reboot metabolism

Use your subscription to reboot your habits – with dedicated lifestyle change support from our bespoke app and in-person support from our expert team

Frequently asked questions

If you’re 18-75 with a BMI over 30 (27 with a weight-related issue) you should be eligible.
As with any prescription medication, there are contraindications to use and our medical team will review your medical history (and blood test results if you choose to have them) to check you are safe to have the treatment. Not eligible during pregnancy / breastfeeding.

GLP-1 medication works by mimicking your body’s natural hormones to suppress your appetite and regulate your hunger.
You’ll feel satisfied eating smaller meals and lose weight by reducing your calorie intake. If using a pre-filled pen, you’ll take an injection at home into your stomach, arm or thigh, It’s quick, easy and painless.

Some people experience side effects with GLP-1, although not everyone will experience them. The most common side effects patients might experience are nausea, diarrhoea, constipation, and vomiting. These usually go away after a few days or weeks on continued treatment.

GLP-1 medications when combined with Weight Loss clinic expert guidance can showcase results in 2-3 months  

Ozempic and Wegovy both contain the active ingredient semaglutide, Ozempic is primarily used for managing type 2 diabetes and has been on the market since 2017, studies found it can also aid in weight loss. On the other hand, Wegovy is a newer medication specifically licensed for weight loss. Although both medications elicit the same physiological response, differences lie in factors such as semaglutide dosage and the medical conditions they are marketed for.

We are aware of potential interactions between weight loss medications and other drugs, which is why our assessment will prompt you to confirm all medications you are currently taking. Our team will also review your allergies and family history to ensure your safety and eligibility for the medication.

We recommend dedicating yourself to a weight loss plan for 8-12 months to maintain continuous progress. It’s important to understand that weight loss medication is not a permanent solution but rather a supportive tool in your weight loss journey. Long-term success depends on making sustainable lifestyle changes

GLP-1 medications are typically safe for the majority of individuals. In a recent trial involving 1,171 participants taking GLP-1 medications, 9.8% experienced serious adverse events. Serious adverse events are those that significantly impact an individual’s quality of life and often result in discontinuation of the medication. However, it’s important to note that the majority of patients experience mild or no side effects from the medication.